The median serum PRL levels of NSCLC patients were 32.0 (IQR: 15.3–53.3) ng/ml, significantly higher than that of healthy controls (median: 11.9 ng/ml, IQR: 7.9–11.9, P < 0.0001, Figure 1). Here, PRL is linked to non-small cell lung carcinoma.